Don’t trust us, trust Science: Abbott is among the best science-based companies to work for in the world.
For the 13th consecutive year, the journal Science today recognized Abbott on its Top Employers list, evaluated on 23 characteristics including financial strength, easy adaptation to change and a having a research-driven environment.
”Abbott is unique in that we’ve been adding to our reservoir of scientific knowledge for 128 years,“ said John Frels, Ph.D., chair of Abbott’s Scientific Governing Board, which oversees the company’s senior scientific career track. ”We strive to bring in the best and brightest scientists and engineers to work on some of the biggest problems in healthcare today. This helps us to create new, breakthrough innovations that change people’s lives.“
To view the multimedia release go to:
http://www.multivu.com/players/English/7962251-science-names-abbott-2016-top-employer/
In her newest YA novel, VASSA IN THE NIGHT, Sarah Porter has merged the dark, forested world of Russian folklore with the gritty, urban streets of Brooklyn to vibrant and dramatic effect.
In the enchanted kingdom of Brooklyn, the fashionable people put on cute shoes, go to parties in warehouses, drink on rooftops at sunset, and tell themselves they’ve arrived. Babs Yaga, the owner of the local convenience store, has a policy of beheading shoplifters—and sometimes innocent shoppers as well. So when Vassa’s stepsister sends her out for light bulbs in the middle of night, she knows it could easily become a suicide mission.
But Vassa has a bit of luck hidden in her pocket, a gift from her dead mother. Erg is a tough-talking wooden doll with sticky fingers, a bottomless stomach, and a ferocious cunning. With Erg’s help, Vassa just might be able to break the witch’s curse and free her Brooklyn neighborhood. But Babs won’t be playing fair….
Find out more at http://www.sarahporterbooks.com/ YA/Fantasy
WebMD Health Corp. (NASDAQ: WBMD), the leading source of health information, today announced the winners of its 2016 Health Hero Awards (http://www.webmd.com/healthheroes/what-is-hero), recognizing individuals who are changing the healthcare landscape by meeting a health challenge and giving back to others. This year’s winners are Seth Rogen and Lauren Miller Rogen, Ed Damiano, PhD, Betty Ferrell, RN, PhD and Trisha Prabhu.
On November 3, 2016, an accomplished and inspiring lineup of presenters and performers will gather to honor the winners at the 3rd Annual WebMD Health Hero Awards gala, hosted by Good Morning America co-anchor Robin Roberts. This year’s presenters include David Krumholtz, Adam Savage, and Sarah Wynter, with musical performances by A Great Big World and Naturally 7.
To watch the red carpet arrivals as they happen live from the TimesCenter in New York City, follow WebMD on www.facebook.com/webmd beginning at 6:30 PM ET on November 3, and be sure to follow @WebMD on Instagram, Snapchat and Twitter for updates throughout the night with #HealthHeroes.
To view the multimedia release go to:
http://www.multivu.com/players/English/7579756-webmd-2016-health-hero-awards/
The National Center for Missing & Exploited Children® and EMCOR Group, Inc.® (NYSE: EME), today announced the launch of Safety Central, a free child safety app available for Apple and Android devices. The app is designed to help parents and guardians protect their families and act quickly should their child go missing.
“Timing is critical when a child is missing and Safety Central lets parents provide the tools that law enforcement needs to start the search with just the touch of a button,” said John Walsh, NCMEC co-founder and host of CNN’s “The Hunt.” “This may be the most important App you’ll have on your device.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7925051-ncmec-emcor-safety-central-app/
Today, Cision announced the launch of its integrated platform, the Cision Communication Cloud™.
This new offering is the first of its kind in the UK and European communications industry to bring the power of the cloud to earned media and incorporates many of Cision’s award-winning technologies, including Gorkana and PR Newswire products and services, into a single integrated platform, providing an effective way to connect, scale and accurately measure the impact of earned media communications.
Jeremy Thompson, CEO (EMEA & India), Cision/PR Newswire, said: “At Cision, we appreciate that PRs and communicators are busier than ever before, as the power and importance of reputation grows. We have set out to help our users assert control by integrating the essential communications data sets and tools they need at their fingertips in one place.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7961251-cision-communication-cloud/
Antibiyotikler neden günümüzde gitgide daha az işe yaramaya başladı ? Hangi süreçler sonucu bakteriler dirençli olmaya başladılar ? Bunun doğal seçilim ile ne alakası olduğunu merak ediyorsanız seyretmenizi tavsiye ederim.
Faydalı mutasyon örnekleri: http://www.baharkilic.org/post/2011/05/29/Faydali-mutasyonlar.aspx
Studies show that more than two-thirds of aesthetically-oriented consumers are bothered by submental fullness, or “double chin.” And with social media profile images becoming more important than ever, there is interest in looking one’s best.
Submental fullness due to fat beneath the chin can impact a broad range of both men and women and because the condition can be genetic and resistant to diet and exercise. But there’s KYBELLA®, the first and only FDA-approved injectable treatment that is available by prescription only, that has been proven to improve the appearance of moderate to severe fat beneath the chin by physically destroying fat cells in the treatment area. In two pivotal clinical studies for KYBELLA®, reductions in submental fat volume were observed more frequently in the KYBELLA® treated group of 514 patients compared to the placebo group (508 patients) as measured by both clinician and patient ratings. In addition, visual and emotional impacts of submental fat (happy, bothered, self-conscious, embarrassed, looking older or overweight) were evaluated using a 6-question survey and 79% of 1 and 2-grade composite responders reported satisfaction after 12 weeks post final treatment compared with 33.6% of patients who received placebo.
To view the multimedia release go to:
http://www.multivu.com/players/English/7962051-kybella-injectable-double-chin-treatment-campaign/
Sentetik biyoloji, bilim dünyasında giderek önem kazanmaya başlayan bir alan haline geldi. İngiltere hükümeti de bu alanı öncelikleri arasına aldı. Bu yeni bilim dalı, daha önce doğada varolmayan canlı organizmayı tasarlayıp yaratmayı amaçlıyor. Çalışmayı yürüten bilim insanları, bu sıradışı teknolojiyle yeni yakıt ve ilaç türleri için büyük bir fırsat doğacağı görüşünde. Ancak çevreciler, bu yeni organizmaların doğaya yayılmasının risklerine dikkat çekiyor.
http://www.bbc.co.uk/turkce/multimedya/2012/03/120329_dg_synthetic_biology.shtml
Napa Valley’s largest independent resort, The Meritage Resort and Spa receives the Platinum Choice Award by Smart Meetings, the meeting industry’s premier resource for meeting professionals. The award recognizes the property for its exemplary standards of excellence in ambiance, amenities, breadth of resources, facility quality, guest services, meeting space and packages, dining options, recreational activities and technical support. Votes were cast by industry professionals, the Smart Meetings editorial team and its readers.
“We are honored to be named one of the best hotels and resorts for meetings and special events in the United States, Canada, Mexico and the Caribbean,” said Sheri Thomas, director of sales and marketing for The Meritage Resort and Spa. “As the largest independent hotel or resort in Napa, Sonoma and Marin counties, we continually strive to provide top quality service and amenities to each of our guests and groups. This award reinforces our commitment to excellence and is a true testament to our team members’ dedication to ensuring that no detail goes unmissed.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7583051-meritage-resort-spa-smart-meetings-award/
Gigi gives us the boot! This fall, Stuart Weitzman has collaborated with Gigi Hadid, the face of the Fall 2016 ad campaign, on an exclusive design for the brand -- the Gigi Boot. The hiker-inspired high heel combat bootie was co-designed by the social supermodel and reflects her sleek street style and fashion-forward flair.
Hadid was inspired by the brand’s stellar boot reputation, but used her creative vision to put a unique, personal spin on the lace-up bootie silhouette. The Gigi Boot is set on a stacked heel, boasts bold metallic eyelets accented by duo-toned laces designed to wrap around the ankle and is finished with a detailed collar. The bootie is available in three materials, so there are multiple options for her style squad: a classic-yet-modern nero soft croco-calf leather and two shiny chic metallics, including iron specchio and copper glass. The bootie comes in a signature Gigi Hadid box and is available exclusively at Stuart Weitzman retail locations and global websites. The retail price is $565 for the metallic styles and $598 for the nero soft croco-calf version.
To view the multimedia release go to:
http://www.multivu.com/players/English/7961351-stuart-weitzman-gigi-hadid-boot/
StarKist® announced today that Charlie® the Tuna, the alTUNAtive 2016 Presidential Candidate, is launching a nation-wide Facebook sweepstakes to help find his ideal Vice Presidential Candidate.
Charlie® and his trustworthy StarKist® political counsel have already selected three potential swimming-mates, but they are leaving the final decision up to the fans. Participants who cast a vote through November 2nd will be entered for a chance to win four years worth of tuna, the length of Charlie’s® potential first presidential term. The official VP and the grand prize winner will be announced on November 3rd.
To view the multimedia release go to:
http://www.multivu.com/players/English/7909331-starkist-president-charlie-the-tuna/
The following statement is being issued by Branstetter, Stranch & Jennings, PLLC regarding In re Prograf Antitrust Litigation.
A lawsuit is currently pending claiming that Astellas Pharma US, Inc. (“Astellas” or “Defendant”) violated state antitrust, unfair competition, consumer protection, and unjust enrichment laws of certain states by delaying the availability of a less expensive generic version of the immunosuppressant prescription drug Prograf® (known as tacrolimus). Plaintiffs allege that Defendant’s conduct caused some consumers and third party payors to pay too much for Prograf in certain states from September 3, 2008 to December 31, 2010 (also referred to as the “Class Damage Period”). This lawsuit does not claim that Prograf is unsafe or ineffective. Astellas denies any wrongdoing.
To view the multimedia release go to:
http://www.multivu.com/players/English/7933851-prograf-antitrust-class-action-settlement/
